chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fall, Fatigue, Hypoaesthesia, Migraine
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Nausea, Neck pain, Nystagmus, Paraesthesia
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: fell down; vertigo; dizziness; nystagmus; tinnitus; migraines; neck pain; facial numbness and twitching; facial numbness and twitching; fatigue; nausea; tingling; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history included COVID-19 (If covid prior vaccination: Yes). No known allergies. The patient was not pregnant. Concomitant medications included sertraline, alprazolam (XANAX), paracetamol (TYLENOL), ascorbic acid, betacarotene, biotin, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, folic acid, iodine, iron, magnesium, manganese, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate, tocopheryl acetate, tocopheryl acid succinate, zinc (PRENATAL [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM PANTOTHENATE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE). The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:00 AM (Batch/Lot number was not reported) as single dose (at the age of 36-years-old) for COVID-19 immunization. On 22May2021 12:00, 48 hours after vaccine, the patient fell down from severe vertigo, dizziness, nausea, fatigue, nystagmus, tinnitus, migraines, neck pain, tingling, facial numbness and twitching. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Therapeutic measures were taken as a result of the events which included Vestibular therapy. Ent. Steroids. Antibiotics. The outcome of the events was not recovered. Not covid tested post vaccination.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Arthralgia, Condition aggravated, Fatigue, Laboratory test normal
Clinical narrative: lupus; significant increase in hair loss; increased fatigue; joint pain; the feeling of swelling in joints and in particular hands and feet; the feeling of swelling in joints and in particular hands and feet; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 02Sep2021 (Lot Number: EW0186) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included COVID-19, lupus, joint pain. Patient was not pregnant. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); omeprazole; famotidine; vitamin d nos; curcuma longa (TURMERIC [CURCUMA LONGA]) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient previously took antibiotics and experienced neurological reactions, and experienced allergies. The patient experienced lupus, significant increase in hair loss, increased fatigue, joint pain, the feeling of swelling in joints and in particular hands and feet in Sep2021. Clinical course reported as: In addition to the normal side effects that were fairly strong and lasted for several days for me, I also had significant increase in hair loss that began in the days after the vaccine and has continued to the present day (almost 5 weeks post injection); increased fatigue; joint pain and the feeling of swelling in joints and in particular hands and feet. Everything has gradually improved (although still present) except the hair loss. The joint pain was a problem in the past with lupus but has not been an issue for many years and it just started again after the vaccine. I have not received the second injection yet due to these lingering symptoms. No treatment received for the events. Outcome of events was recovering.  AE resulted in Doctor or other healthcare professional office/clinic visit.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Systemic lupus erythematosus
Clinical narrative: lupus; significant increase in hair loss; increased fatigue; joint pain; the feeling of swelling in joints and in particular hands and feet; the feeling of swelling in joints and in particular hands and feet; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 02Sep2021 (Lot Number: EW0186) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included COVID-19, lupus, joint pain. Patient was not pregnant. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); omeprazole; famotidine; vitamin d nos; curcuma longa (TURMERIC [CURCUMA LONGA]) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient previously took antibiotics and experienced neurological reactions, and experienced allergies. The patient experienced lupus, significant increase in hair loss, increased fatigue, joint pain, the feeling of swelling in joints and in particular hands and feet in Sep2021. Clinical course reported as: In addition to the normal side effects that were fairly strong and lasted for several days for me, I also had significant increase in hair loss that began in the days after the vaccine and has continued to the present day (almost 5 weeks post injection); increased fatigue; joint pain and the feeling of swelling in joints and in particular hands and feet. Everything has gradually improved (although still present) except the hair loss. The joint pain was a problem in the past with lupus but has not been an issue for many years and it just started again after the vaccine. I have not received the second injection yet due to these lingering symptoms. No treatment received for the events. Outcome of events was recovering.  AE resulted in Doctor or other healthcare professional office/clinic visit.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Arthralgia, Fatigue, Joint swelling, Peripheral swelling
Clinical narrative: lupus; significant increase in hair loss; increased fatigue; joint pain; the feeling of swelling in joints and in particular hands and feet; the feeling of swelling in joints and in particular hands and feet; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 02Sep2021 (Lot Number: EW0186) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included COVID-19, lupus, joint pain. Patient was not pregnant. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); omeprazole; famotidine; vitamin d nos; curcuma longa (TURMERIC [CURCUMA LONGA]) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient previously took antibiotics and experienced neurological reactions, and experienced allergies. The patient experienced lupus, significant increase in hair loss, increased fatigue, joint pain, the feeling of swelling in joints and in particular hands and feet in Sep2021. Clinical course reported as: In addition to the normal side effects that were fairly strong and lasted for several days for me, I also had significant increase in hair loss that began in the days after the vaccine and has continued to the present day (almost 5 weeks post injection); increased fatigue; joint pain and the feeling of swelling in joints and in particular hands and feet. Everything has gradually improved (although still present) except the hair loss. The joint pain was a problem in the past with lupus but has not been an issue for many years and it just started again after the vaccine. I have not received the second injection yet due to these lingering symptoms. No treatment received for the events. Outcome of events was recovering.  AE resulted in Doctor or other healthcare professional office/clinic visit.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Systemic lupus erythematosus
Clinical narrative: lupus; significant increase in hair loss; increased fatigue; joint pain; the feeling of swelling in joints and in particular hands and feet; the feeling of swelling in joints and in particular hands and feet; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 02Sep2021 (Lot Number: EW0186) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included COVID-19, lupus, joint pain. Patient was not pregnant. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); omeprazole; famotidine; vitamin d nos; curcuma longa (TURMERIC [CURCUMA LONGA]) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient previously took antibiotics and experienced neurological reactions, and experienced allergies. The patient experienced lupus, significant increase in hair loss, increased fatigue, joint pain, the feeling of swelling in joints and in particular hands and feet in Sep2021. Clinical course reported as: In addition to the normal side effects that were fairly strong and lasted for several days for me, I also had significant increase in hair loss that began in the days after the vaccine and has continued to the present day (almost 5 weeks post injection); increased fatigue; joint pain and the feeling of swelling in joints and in particular hands and feet. Everything has gradually improved (although still present) except the hair loss. The joint pain was a problem in the past with lupus but has not been an issue for many years and it just started again after the vaccine. I have not received the second injection yet due to these lingering symptoms. No treatment received for the events. Outcome of events was recovering.  AE resulted in Doctor or other healthcare professional office/clinic visit.  Follow-up attempts are completed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cough, Fatigue, Influenza like illness, Laboratory test abnormal, Myalgia
Clinical narrative: BODY ACHES, COUGH, SHORTNESS OF BREATH, FATIGUE, SLEEPING MORE, COVID PNEUMONIA
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: BODY ACHES, COUGH, SHORTNESS OF BREATH, FATIGUE, SLEEPING MORE, COVID PNEUMONIA
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Fatigue, Pain
Clinical narrative: BODY ACHES, COUGH, SHORTNESS OF BREATH, FATIGUE, SLEEPING MORE, COVID PNEUMONIA
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Somnolence
Clinical narrative: BODY ACHES, COUGH, SHORTNESS OF BREATH, FATIGUE, SLEEPING MORE, COVID PNEUMONIA
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Pruritus, Skin warm
Clinical narrative: At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; This is a spontaneous report from a contactable consumer or other non hcp (Patient reported for self). A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: FC3184), dose 3 via an unspecified route of administration, administered in Left arm on 07Oct2021 18:00 as dose 3 (booster), single for COVID-19 immunisation. Medical history included High blood pressure from an unknown date and unknown if ongoing. Concomitant medication(s)/ Other medications in two weeks included escitalopram; bupropion hcl; amlodipine besylate all taken for unspecified indication(s), start and stop date(s) were not reported. The patient had earlier received second dose of BNT162B2 (lot number EN6199) via unspecified route of administration, administered in the Left arm on 24Mar2021 at 17:00 as dose 2, single and the first dose of BNT162B2 (lot number EN6201) via unspecified route of administration, administered in Left arm on 03Mar2021 at 18:00 both at the age of 34-Years old as dose 1, single for COVID-19 immunisation. No other vaccine in four weeks. No COVID prior vaccination. On 08Oct2021 at 1:15-1:30am the patient woke up with extremely itchy, swollen, and burning feet/toes (reported as, At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes). Adverse event did not result in emergency room or physician office visit. Patient was not tested for COVID post vaccination The patient did not received treatment for the adverse event. The events were non-serious. The outcome of the events was recovering.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Peripheral swelling, Pruritus
Clinical narrative: At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes.; This is a spontaneous report from a contactable consumer or other non hcp (Patient reported for self). A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: FC3184), dose 3 via an unspecified route of administration, administered in Left arm on 07Oct2021 18:00 as dose 3 (booster), single for COVID-19 immunisation. Medical history included High blood pressure from an unknown date and unknown if ongoing. Concomitant medication(s)/ Other medications in two weeks included escitalopram; bupropion hcl; amlodipine besylate all taken for unspecified indication(s), start and stop date(s) were not reported. The patient had earlier received second dose of BNT162B2 (lot number EN6199) via unspecified route of administration, administered in the Left arm on 24Mar2021 at 17:00 as dose 2, single and the first dose of BNT162B2 (lot number EN6201) via unspecified route of administration, administered in Left arm on 03Mar2021 at 18:00 both at the age of 34-Years old as dose 1, single for COVID-19 immunisation. No other vaccine in four weeks. No COVID prior vaccination. On 08Oct2021 at 1:15-1:30am the patient woke up with extremely itchy, swollen, and burning feet/toes (reported as, At about 1:15-1:30am woke up with extremely itchy, swollen, and burning feet/toes). Adverse event did not result in emergency room or physician office visit. Patient was not tested for COVID post vaccination The patient did not received treatment for the adverse event. The events were non-serious. The outcome of the events was recovering.
Age: 64.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash, Urticaria
Clinical narrative: terrible rash, initially on his legs; in the beginning it started out as "hives"; has left scarring from where he had itched (scratched).; describe the rash as red; describe the rash like "a poison ivy and mosquito bite itching; Scratching; This case was reported by a consumer via call center representative and described the occurrence of rash in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th June 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced rash, hives, scar, red rash, itchy rash and scratch. On an unknown date, the outcome of the rash, hives, scar, red rash, itchy rash and scratch were not recovered/not resolved.   The reporter considered the rash, hives, scar, red rash, itchy rash and scratch to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself. The patient received a dose of Shingrix in left arm and experienced a terrible rash that he has had for 3 months and it progressively got worse after the second shot. He thought that it may be related to Shingrix. He stated that the best way to describe the rash is that his arms and chest look like he felt slept on the beach with no sunscreen. It was that red as it felt like a combination of poison ivy and mosquito bite itching along with the worst sunburn it ever had. The patient had seen a general practitioner and an allergist and was wondering if he should see an infectious disease specialist. He indicated that in the beginning it started out as hives but was now blown out. He said that initially it was on his legs then it dissipated from his legs and has left scarring from where he had itched (scratched). At the time of reporting, the rash was more concentrated on his upper torso, chest, arms, and on his back were his lats (latissimus dorsi) are. Rash was not resolved. The reporter consented to follow-up. For tolerance of 2nd dose, refer case US2021AMR211153.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR211153:same reporter and patient
Age: 64.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Arthropod bite, Dermatitis contact, Itching scar, Rash, Rash erythematous
Clinical narrative: terrible rash, initially on his legs; in the beginning it started out as "hives"; has left scarring from where he had itched (scratched).; describe the rash as red; describe the rash like "a poison ivy and mosquito bite itching; Scratching; This case was reported by a consumer via call center representative and described the occurrence of rash in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th June 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced rash, hives, scar, red rash, itchy rash and scratch. On an unknown date, the outcome of the rash, hives, scar, red rash, itchy rash and scratch were not recovered/not resolved.   The reporter considered the rash, hives, scar, red rash, itchy rash and scratch to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself. The patient received a dose of Shingrix in left arm and experienced a terrible rash that he has had for 3 months and it progressively got worse after the second shot. He thought that it may be related to Shingrix. He stated that the best way to describe the rash is that his arms and chest look like he felt slept on the beach with no sunscreen. It was that red as it felt like a combination of poison ivy and mosquito bite itching along with the worst sunburn it ever had. The patient had seen a general practitioner and an allergist and was wondering if he should see an infectious disease specialist. He indicated that in the beginning it started out as hives but was now blown out. He said that initially it was on his legs then it dissipated from his legs and has left scarring from where he had itched (scratched). At the time of reporting, the rash was more concentrated on his upper torso, chest, arms, and on his back were his lats (latissimus dorsi) are. Rash was not resolved. The reporter consented to follow-up. For tolerance of 2nd dose, refer case US2021AMR211153.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR211153:same reporter and patient
Age: 64.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash pruritic, Scratch, Urticaria
Clinical narrative: terrible rash, initially on his legs; in the beginning it started out as "hives"; has left scarring from where he had itched (scratched).; describe the rash as red; describe the rash like "a poison ivy and mosquito bite itching; Scratching; This case was reported by a consumer via call center representative and described the occurrence of rash in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th June 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced rash, hives, scar, red rash, itchy rash and scratch. On an unknown date, the outcome of the rash, hives, scar, red rash, itchy rash and scratch were not recovered/not resolved.   The reporter considered the rash, hives, scar, red rash, itchy rash and scratch to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself. The patient received a dose of Shingrix in left arm and experienced a terrible rash that he has had for 3 months and it progressively got worse after the second shot. He thought that it may be related to Shingrix. He stated that the best way to describe the rash is that his arms and chest look like he felt slept on the beach with no sunscreen. It was that red as it felt like a combination of poison ivy and mosquito bite itching along with the worst sunburn it ever had. The patient had seen a general practitioner and an allergist and was wondering if he should see an infectious disease specialist. He indicated that in the beginning it started out as hives but was now blown out. He said that initially it was on his legs then it dissipated from his legs and has left scarring from where he had itched (scratched). At the time of reporting, the rash was more concentrated on his upper torso, chest, arms, and on his back were his lats (latissimus dorsi) are. Rash was not resolved. The reporter consented to follow-up. For tolerance of 2nd dose, refer case US2021AMR211153.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR211153:same reporter and patient
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Pulmonary Embolism; Covid Test Result-Positive Date Aug2021; Covid Test Result-Positive Date Aug2021; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 06Jan2021 (lot number: E13246), then second dose on 27Jan2021 (lot number: E19262), both via unspecified route of administration administered in the right arm as single dose for covid-19 immunisation. Medical history included known allergy to Sulfa. The patient has no covid prior to vaccination and no other vaccine in four weeks. Concomitant medication included an unspecified oral contraceptive. The patient previously took thiomersal and experienced allergy. The patient experienced pulmonary embolism on 28Jun2021. The patient was hospitalized for four days due to the event and was given heparin and Xarelto after hospital stay. The patient had a nasal swab/PCR test on Aug2021 and the result was positive. The patient was recovering from pulmonary embolism at the time of the report while outcome of covid-19 positive was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pulmonary embolism, Vaccination failure
Clinical narrative: Pulmonary Embolism; Covid Test Result-Positive Date Aug2021; Covid Test Result-Positive Date Aug2021; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 06Jan2021 (lot number: E13246), then second dose on 27Jan2021 (lot number: E19262), both via unspecified route of administration administered in the right arm as single dose for covid-19 immunisation. Medical history included known allergy to Sulfa. The patient has no covid prior to vaccination and no other vaccine in four weeks. Concomitant medication included an unspecified oral contraceptive. The patient previously took thiomersal and experienced allergy. The patient experienced pulmonary embolism on 28Jun2021. The patient was hospitalized for four days due to the event and was given heparin and Xarelto after hospital stay. The patient had a nasal swab/PCR test on Aug2021 and the result was positive. The patient was recovering from pulmonary embolism at the time of the report while outcome of covid-19 positive was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, Illness, Intensive care
Clinical narrative: Pt Admitted on 10/10/2021: co illness x 5-6 days with shortness of breath and increasing weakness. negative home covid test 3 days ago. arrives tachypneic, in RD, with O2 54% on RA. history per pt son. History of Present Illness:   Patient is a 74-year-old male presents to the ER complaining of shortness of breath which started 5-6 days ago.  He took an in-home COVID test 3 days ago was negative.  He tells me had 2 doses of earlier this year  and had the pfizer booster 9-30-21.  In the ED tested positive for COVID.  In triage, patient's room air O2 sat was 54% on room.  He denies any fever chills or any known lung disease.  He says he is a nonsmoker takes no medications and has no cough past medical problems that he aware of. Discussed with him code status at this point he would want to be full code.  History limited by patient's hers shortness of breath despite high-flow oxygen.  Pt is current in-patient.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Pt Admitted on 10/10/2021: co illness x 5-6 days with shortness of breath and increasing weakness. negative home covid test 3 days ago. arrives tachypneic, in RD, with O2 54% on RA. history per pt son. History of Present Illness:   Patient is a 74-year-old male presents to the ER complaining of shortness of breath which started 5-6 days ago.  He took an in-home COVID test 3 days ago was negative.  He tells me had 2 doses of earlier this year  and had the pfizer booster 9-30-21.  In the ED tested positive for COVID.  In triage, patient's room air O2 sat was 54% on room.  He denies any fever chills or any known lung disease.  He says he is a nonsmoker takes no medications and has no cough past medical problems that he aware of. Discussed with him code status at this point he would want to be full code.  History limited by patient's hers shortness of breath despite high-flow oxygen.  Pt is current in-patient.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, Illness, SARS-CoV-2 test positive
Clinical narrative: Pt Admitted on 10/10/2021: co illness x 5-6 days with shortness of breath and increasing weakness. negative home covid test 3 days ago. arrives tachypneic, in RD, with O2 54% on RA. history per pt son. History of Present Illness:   Patient is a 74-year-old male presents to the ER complaining of shortness of breath which started 5-6 days ago.  He took an in-home COVID test 3 days ago was negative.  He tells me had 2 doses of earlier this year  and had the pfizer booster 9-30-21.  In the ED tested positive for COVID.  In triage, patient's room air O2 sat was 54% on room.  He denies any fever chills or any known lung disease.  He says he is a nonsmoker takes no medications and has no cough past medical problems that he aware of. Discussed with him code status at this point he would want to be full code.  History limited by patient's hers shortness of breath despite high-flow oxygen.  Pt is current in-patient.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Tachypnoea
Clinical narrative: Pt Admitted on 10/10/2021: co illness x 5-6 days with shortness of breath and increasing weakness. negative home covid test 3 days ago. arrives tachypneic, in RD, with O2 54% on RA. history per pt son. History of Present Illness:   Patient is a 74-year-old male presents to the ER complaining of shortness of breath which started 5-6 days ago.  He took an in-home COVID test 3 days ago was negative.  He tells me had 2 doses of earlier this year  and had the pfizer booster 9-30-21.  In the ED tested positive for COVID.  In triage, patient's room air O2 sat was 54% on room.  He denies any fever chills or any known lung disease.  He says he is a nonsmoker takes no medications and has no cough past medical problems that he aware of. Discussed with him code status at this point he would want to be full code.  History limited by patient's hers shortness of breath despite high-flow oxygen.  Pt is current in-patient.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Body temperature increased, COVID-19, Chest X-ray normal, Computerised tomogram head normal, Computerised tomogram spine
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea, Fall, Hypoxia, Intervertebral disc degeneration
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: PO2 decreased, SARS-CoV-2 test positive
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood culture positive, Blood magnesium decreased, Body temperature increased, COVID-19
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Chest X-ray, Confusional state, Cough, Disorientation, Fall
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoxia, Memory impairment, Metabolic encephalopathy, Mineral supplementation, SARS-CoV-2 test positive
Clinical narrative: Admission: 10/11/2021:  pt arrives via EMS after falling from ground level. Pt is not oriented to time. pt does not remember the event TB# B886127;    Patient is noted to be mildly hypoxic on pulse ox in the emergency room.  And also EMS reported that she had a temperature of a 101°.  She has not been febrile in the emergency room.  The patient's daughter reports having COVID approximately 6 weeks ago.  She was diagnosed on 08/30/2021.  The patient herself had an initial to vaccinations in January in February this year and the daughter reports that she had a booster approximately 1 week ago.  The patient has not really had any cough.  She may have had some mild shortness of breath.  No diarrhea reported.  On blood gas in the emergency room the patient has a PO2 of 55.  The patient also has a history of COPD and according to the daughter has been out of her Breo Ellipta for approximately 2 weeks.  Patient is not normally on oxygen at home.  Chest x-ray in the emergency room tonight does not look particularly bad.  It actually appears unchanged from her previous chest x-rays.  I have been asked to admit the patient due to her COVID positivity and mild hypoxia.  The daughter does report that the patient has had a mild cough which she thinks has been present for a couple of weeks.   Pt discharged on 10/15/2021:  She was diagnosed with COVID-19.  She was initially started on dexamethasone.  Couple of days into her hospital course, she was encephalopathic and her steroid was stopped in case it was contributing to her confusion.  Regarding her hypoxia, she required anywhere from room air to 2 L of oxygen.  Regarding her weakness and falls, she was evaluated by Physical Therapy, it was recommended to go to rehab.  Arrangements were made for her to go to her local clinic.  Her magnesium was low and was replaced.  It will need to be monitored as an outpatient.  She is on a proton pump inhibitor.  She did have 1 out of 2 positive blood cultures that was a contaminant.  Regarding her acute metabolic encephalopathy, this resolved with stopping her dexamethasone.  By October 15, she was accepted to another facility.